H
Haisco
Novel chemical entity development for global pharmaceutical markets.
At a glance
- Status
- Listed
- Founded
- 2000
- Headquarters
- Lhoka, China
- Listing
- IPO 2012
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- FFFullgoal Fund
JP Morgan
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Patents
380 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Haisco was the backer or acquirer, 2015–2019. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
6 deals across Haisco's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Haisco deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Haisco's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Haisco on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Haisco on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.